Advancements In Hematopoietic Stem Cell Therapy
Keywords:
Hematopoietic Stem Cell Therapy, Patient Satisfaction, Age, Product Usage Frequency, Regression Analysis, Normality, Cronbach’s Alpha, Healthcare SatisfactionAbstract
Background: Over the past few years, Hematopoietic Stem Cell Therapy (HSCT) has made remarkable progress in taking diseases away from patients like leukemia, lymphoma, or sickle cell anemia. Even with clinical success, satisfaction remains a major concern for patients treated. Introduction The study aimed to investigate factors related to satisfaction in HSCT and to determine the contribution of demographic, treatment-related, and behavioral variables to satisfaction.
Objective: This study mainly aimed to explore the influence of age, gender, education, occupation, product application frequency, and other treatment-related factors on patient satisfaction with HSCT.
Methods: This research uses a quantitative descriptive research design, using primary and secondary data. HSCT experiences were assessed among a sample of 200 patients and 150 healthcare professionals surveyed using structured questionnaires. A variety of analyses were conducted on the data, including descriptive statistics, normality tests (Shapiro-Wilk), reliability tests (Cronbach’s Alpha), correlation analysis, and regression modeling to predict significant predictors of patient satisfaction.
Results: Results showed a strong negative correlation between Age and Satisfaction, indicating older patients reported a lower satisfaction level. However, the Product Usage Frequency indicated a moderate negative association with satisfaction, implying that the more frequently the treatments were applied, the less satisfied the customers were. Neither gender nor education or occupation was a significant predictor of satisfaction. All tests for normality showed that the data was not normal, thus, we probably would use nonparametric methods.
Conclusion: Age and treatment frequency for HSCT in systematically increasing patient satisfaction: This study suggests the need for further investigation of the association between frequency of treatment and its effect on patient satisfaction in HSCT The results indicate that older patients and more frequently treated patients may have lower satisfaction and should be the focus of further investigation in the context of personalized care strategies. Further research could also include additional factors — psychological well-being, long-term outcomes, etc. — that could provide a broader perspective for the improvement of HSCT patients..
Downloads
Metrics
References
Alexander, T., & Greco, R. (2022). Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases: overview and future considerations from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT). Bone marrow transplantation, 57(7), 1055-1062.
Azhar Ud Din, M., Lin, Y., Lyu, C., Yi, C., Fang, A., & Mao, F. (2025). Advancing therapeutic strategies for graft-versus-host disease by targeting gut microbiome dynamics in allogeneic hematopoietic stem cell transplantation: current evidence and future directions. Molecular Medicine, 31(1), 2.
Batsivari, A., Haltalli, M. L. R., Passaro, D., Pospori, C., Lo Celso, C., & Bonnet, D. (2020). Dynamic responses of the hematopoietic stem cell niche to diverse stresses. Nature Cell Biology, 22(1), 7-17.
Breda, L., Papp, T. E., Triebwasser, M. P., Yadegari, A., Fedorky, M. T., Tanaka, N., Abdulmalik, O., Pavani, G., Wang, Y., & Grupp, S. A. (2023). In vivo hematopoietic stem cell modification by mRNA delivery. Science, 381(6656), 436-443.
Brodsky, R. A. (2023). Advancements and challenges in hematology: From bone marrow transplants to targeted therapeutics. The Hematologist, 20(2).
Carreras, E., Dufour, C., Mohty, M., & Kröger, N. (2019). The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies.
Castagnoli, R., Delmonte, O. M., Calzoni, E., & Notarangelo, L. D. (2019). Hematopoietic stem cell transplantation in primary immunodeficiency diseases: current status and future perspectives. Frontiers in pediatrics, 7, 295.
Cavazzana, M., Bushman, F. D., Miccio, A., André-Schmutz, I., & Six, E. (2019). Gene therapy targeting hematopoietic stem cells for inherited diseases: progress and challenges. Nature reviews Drug discovery, 18(6), 447-462.
Chen, B., & Wang, P. (2025). The eve of a historic breakthrough in the realm of human pluripotent stem cell-derived hematopoietic stem cells. European Cells and Materials, 49, 17-20.
Cho, S.-Y., Lee, D.-G., & Kim, H.-J. (2019). Cytomegalovirus infections after hematopoietic stem cell transplantation: current status and future immunotherapy. International Journal of Molecular Sciences, 20(11), 2666.
Czechowicz, A., Palchaudhuri, R., Scheck, A., Hu, Y., Hoggatt, J., Saez, B., Pang, W. W., Mansour, M. K., Tate, T. A., & Chan, Y. Y. (2019). Selective hematopoietic stem cell ablation using CD117-antibody-drug-conjugates enables safe and effective transplantation with immunity preservation. Nature communications, 10(1), 617.
Das, S., Singh, M. P., Balaraman, A. K., Mehta, R., & Sah, S. (2025). Advancements in graft-versus-host disease prevention in hematopoietic stem cell transplantation. Iraqi Journal of Hematology, 10.4103.
Dong, Y., Wu, X., Chen, X., Zhou, P., Xu, F., & Liang, W. (2021). Nanotechnology shaping stem cell therapy: Recent advances, application, challenges, and future outlook. Biomedicine & Pharmacotherapy, 137, 111236.
Duarte, R. F., Labopin, M., Bader, P., Basak, G. W., Bonini, C., Chabannon, C., Corbacioglu, S., Dreger, P., Dufour, C., & Gennery, A. R. (2019). Indications for hematopoietic stem cell transplantation for hematological diseases, solid tumors, and immune disorders: current practice in Europe, 2019. Bone marrow transplantation, 54(10), 1525-1552.
Einsele, H., Ljungman, P., & Boeckh, M. (2020). How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation. Blood, The Journal of the American Society of Hematology, 135(19), 1619-1629.
Feng, J., Zhang, X., Tan, Z., Zhao, Y., Hu, H., Chen, J., Wu, L., Yu, Q., Wu, D., & Ye, B. (2025). Risk factors and clinical outcomes of cytomegalovirus infection following haploidentical hematopoietic stem cell transplantation in patients with aplastic anemia: a single-center retrospective study. Frontiers in Medicine, 11, 1523909.
Golchin, A., & Farahany, T. Z. (2019). Biological products: cellular therapy and FDA-approved products. Stem cell reviews and reports, 15(2), 166-175.
Gu, Q., Yang, X., Lv, J., Zhang, J., Xia, B., Kim, J.-d., Wang, R., Xiong, F., Meng, S., & Clements, T. P. (2019). AIBP-mediated cholesterol efflux instructs hematopoietic stem and progenitor cell fate. Science, 363(6431), 1085-1088.
Hogrebe, N. J., Ishahak, M., & Millman, J. R. (2023). Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes. Cell Stem Cell, 30(5), 530-548.
Hornberger, K., Yu, G., McKenna, D., & Hubel, A. (2019). Cryopreservation of hematopoietic stem cells: emerging assays, cryoprotectant agents, and technology to improve outcomes. Transfusion Medicine and Hemotherapy, 46(3), 188-196.
Hung, C.-Y., Hsueh, T.-Y., Rethi, L., Lu, H.-T., & Chuang, A. E.-Y. (2025). Advancements in regenerative medicine: a comprehensive review of stem cell and growth factor therapies for osteoarthritis. Journal of Materials Chemistry B.
Hwang, W. Y. K., & Muzammil, E. M. (2025). The Current State of Cytotherapy and the Field of Cell and Gene Therapy. Cytotherapy.
Jakharia, N., Howard, D., & Riedel, D. J. (2021). CMV infection in hematopoietic stem cell transplantation: prevention and treatment strategies. Current treatment options in infectious diseases, 13, 123-140.
Kiumarsi, A., Alaei, A., Nikbakht, M., Mohammadi, S., Ostad-Ali, M. R., Rasti, Z., & Rostami, T. (2025). Dual in vivo T cell-depleted haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide and anti-thymocyte globulin as a third salvage transplant for leukocyte adhesion deficiency with graft failure: a case report. Frontiers in immunology, 15, 1475448.
Lattanzi, A., Camarena, J., Lahiri, P., Segal, H., Srifa, W., Vakulskas, C. A., Frock, R. L., Kenrick, J., Lee, C., & Talbott, N. (2021). Development of β-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease. Science translational medicine, 13(598), eabf2444.
Lee, J. Y., & Hong, S.-H. (2020). Hematopoietic stem cells and their roles in tissue regeneration. International journal of stem cells, 13(1), 1-12.
Liu, Y., Li, P., & Yang, Y. (2025). Advancements in Utilizing CD34+ Stem Cells for Repairing Diabetic Vascular Damage. Biochemical and Biophysical Research Communications, 151411.
Mazini, L., Ezzoubi, M., & Malka, G. (2021). Overview of current adipose-derived stem cell (ADSCs) processing involved in therapeutic advancements: flow chart and regulation updates before and after COVID-19. Stem Cell Research & Therapy, 12(1), 1.
Mi, P., Zhong, Y., Xu, Y., & Qin, X. (2025). Advancements in Stem Cell Therapeutics for Spinal Cord Injury: Theories and Applications. Journal of Biosciences and Medicines, 13(1), 102-131.
Paul-Chima, U. O., & Ugo, A. E. (2025). Exploring the Potential of Medicinal Plants in Bone Marrow Regeneration and Hematopoietic Stem Cell Therapy. INTERNATIONAL JOURNAL, 2994, 2594.
Pinho, S., & Frenette, P. S. (2019). Hematopoietic stem cell activity and interactions with the niche. Nature reviews Molecular cell biology, 20(5), 303-320.
Rai, N., Singh, A. K., Singh, S. K., Gaurishankar, B., Kamble, S. C., Mishra, P., Kotiya, D., Barik, S., Atri, N., & Gautam, V. (2020). Recent technological advancements in stem cell research for targeted therapeutics. Drug Delivery and Translational Research, 10, 1147-1169.
Renaghan, A. D., Jaimes, E. A., Malyszko, J., Perazella, M. A., Sprangers, B., & Rosner, M. H. (2020). Acute kidney injury and CKD associated with hematopoietic stem cell transplantation. Clinical Journal of the American Society of Nephrology, 15(2), 289-297.
Sharrack, B., Saccardi, R., Alexander, T., Badoglio, M., Burman, J., Farge, D., Greco, R., Jessop, H., Kazmi, M., & Kirgizov, K. (2020). Autologous hematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE). Bone marrow transplantation, 55(2), 283-306.
Stern, L., Withers, B., Avdic, S., Gottlieb, D., Abendroth, A., Blyth, E., & Slobedman, B. (2019). Human cytomegalovirus latency and reactivation in allogeneic hematopoietic stem cell transplant recipients. Frontiers in Microbiology, 10, 1186.
Wade, J. (2023). A Historical Review of Hematopoietic Stem Cell Transplantation: Developmental Advancements Then and Now. Senior Honors Theses.
Wanat, J., Homa, W., Warunek, A., Gronowicz, G., Dzikowska, I., Siejka, A., Stefaniak, D., Zielińska, W., & Chról, M. (2025). Advancements in the Treatment of Mucopolysaccharidoses: From Established Therapies to Gene Therapy. Journal of Education, Health and Sport, 78, 57726-57726.
Yusoff, N. A., Abd Hamid, Z., Taib, I. S., Abdul Razak, S. R., & Budin, S. B. (2025). Exploring Epigenetic Complexity in Regulation of Hematopoietic Stem Cells Niche: A Mechanistic Journey from Normal to Malignant Hematopoiesis. In. Springer.
Zhang, C., & Liu, H. (2025). Advancements and Future Directions of Dual‐Target Chimeric Antigen Receptor T‐Cell Therapy in Preclinical and Clinical Studies. Journal of Immunology Research, 2025(1), 5845167.
Zhang, P., Zhang, C., Li, J., Han, J., Liu, X., & Yang, H. (2019). The physical microenvironment of hematopoietic stem cells and its emerging roles in engineering applications. Stem Cell Research & Therapy, 10, 1-13.
Zhang, X.-h., Chen, J., Han, M.-Z., Huang, H., Jiang, E.-l., Jiang, M., Lai, Y.-r., Liu, D.-h., Liu, Q.-F., & Liu, T. (2021). The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update. Journal of hematology & oncology, 14, 1-20
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
